Select Medical Holdings Rating Increased to Outperform at Zacks (SEM)
Select Medical Holdings (NYSE:SEM) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday, AmericanBankingNews.com reports. The firm currently has a $14.70 price objective on the stock. Zacks‘s target price suggests a potential upside of 5.00% from the company’s current price.
Select Medical Holdings (NYSE:SEM) traded up 0.07% during mid-day trading on Wednesday, hitting $14.00. 811,197 shares of the company’s stock traded hands. Select Medical Holdings has a one year low of $7.66 and a one year high of $14.49. The stock’s 50-day moving average is $13.13 and its 200-day moving average is $10.93. The company has a market cap of $1.830 billion and a P/E ratio of 17.31.
Select Medical Holdings (NYSE:SEM) last announced its earnings results on Thursday, May 1st. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.01. The company had revenue of $762.60 million for the quarter, compared to the consensus estimate of $760.50 million. During the same quarter in the previous year, the company posted $0.25 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, analysts predict that Select Medical Holdings will post $0.94 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, May 28th. Investors of record on Friday, May 16th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 2.86%. The ex-dividend date is Wednesday, May 14th.
Other equities research analysts have also recently issued reports about the stock. Analysts at Robert W. Baird raised their price target on shares of Select Medical Holdings from $15.00 to $16.00 in a research note on Monday. Separately, analysts at Susquehanna raised their price target on shares of Select Medical Holdings from $15.00 to $20.00 in a research note on Monday. Finally, analysts at RBC Capital upgraded shares of Select Medical Holdings from a “sector perform” rating to an “outperform” rating in a research note on Monday, April 7th. They now have a $21.00 price target on the stock, up previously from $9.00. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $16.64.
In other Select Medical Holdings news, SVP Scott Romberger sold 75,000 shares of the stock on the open market in a transaction dated Monday, May 5th. The shares were sold at an average price of $13.90, for a total value of $1,042,500.00. Following the completion of the transaction, the senior vice president now directly owns 133,830 shares of the company’s stock, valued at approximately $1,860,237. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.